Contract Pharmacy

PSG delivers superior implementation of contract pharmacy services. We have national contract relationships with chains using pre-approved contract templates to streamline the process. Read More

Split billing software

Split-Billing Software

When it comes to split-billing, you need a solution as unique as your business. That’s why PSG customizes split-billing solutions customized around your facility and needs. Read More


Uninsured Patient Programs

PSG helps covered entities extend total access to care for at-risk populations with real-time eligibility determination and enrollment at the point of care. Read More

Specialty Management

Specialty Management

PSG is here to support our customers every step of the way. We start with a thorough evaluation to determine the optimal specialty pharmacies to be included in your network. From there, we proactively work with your pharmacy network to identify and address missed opportunities to maximize savings.Read More

As a health system, you’re doing everything you can to improve the quality of care for patients. Oftentimes, that places additional administrative and compliance challenges on your organization. A prime example is the 340B Drug Pricing Program, which enables health care organizations that care for uninsured/underserved individuals to purchase prescription drugs at discounted prices. The cause is incredibly worthwhile, but the reality of what’s required of health systems to make such a program happen is infinitely complex.

Connect with the Experts

Policy rules, emerging requirements, inventory management, and billing can be overwhelming, even for the most experienced pharmacy director. However, you don’t have to do it alone. This is the time to connect with an expert.

At PSG, that’s why we’re here. We take what was previously an administrative quagmire and transform it into an all-too-rare opportunity-minimizing risk, while also saving valuable health care dollars. With our solutions, you can optimize your pharmacy programs and grow your mission of care.

Privacy Policy


This privacy policy outlines how Pharmaceutical Strategies Group, LLC (PSG), uses and protects client information and data when doing business with PSG. PSG is committed to ensuring that our clients’ privacy and data is secure and protected.


PSG has implemented a security policy that further ensures that our clients’ information and data is secure. In order to prevent unauthorized access or disclosure, we have put in place suitable physical, electronic, and managerial procedures to safeguard and secure the information collected for business purposes.

Method of Data Collection

PSG collects data from clients, pharmacies, hospitals and various other sources mainly through secure file transfer protocol (“SFTP”), but PSG also is provided information via encrypted, password protected CDs, encrypted USB drives and/or encrypted files via email.

Types of Protected Information

The types of information protected by this policy are:  confidential information (CI), such as individually identifiable health information and protected health information (“PHI”), financial information, non-public personal information, and all data exchanged during the course of business to complete the tasks associated with an agreement, consultation, audit, or project.

Additional data and information may include company/client contact names, addresses, email addresses, demographic data, etc. This information may be stored in internal systems, such as sales management applications. These systems permit PSG employees to access and process such data solely for the purpose of customer fulfillment, business administration, business reporting, statistical analysis and marketing of PSG products and services.

Incident Management and Reporting

Employees, contractors, and applicable third-party associated are required to report any suspected breach or policy violation immediately, without unreasonable delay and in no case later than five (5) business days, to their immediate manager. The manager will evaluate the suspected breach or violation and, if validated, will report it to the Chief Financial Officer of PSG. If the breach or violation is validated, the affected client(s) will be notified within a reasonable amount of time. In addition, the notification will include a description of any investigatory steps taken, list of individuals impacted by the incident, the type of information involved in the incident, the date of the potential incident, and the date of discovery.

All incidents, breaches, or violations should be confidentially and immediately reported to:

Pharmaceutical Strategies Group, LLC
2901 N. Dallas Pkwy, Suite 420
Plano, Texas 75093
Attention: Drue Pounds, CFO

Confidentiality and Non-Disclosure Agreements

PSG executes Confidentiality and/or Nondisclosure Agreement with employees, third parties, contracted individuals, and/or contracted organizations performing services that involve the use or disclosure of CI.

Return/Destruction of Information Procedure

When the arrangement between a client and PSG ends, PSG will return or destroy all client/client member and proprietary information received during the course of the working relationship/project. In most cases, PSG will not retain any copies of the information, unless otherwise noted or agreed. If the return or destruction of this information is not feasible, PSG will continue to extend the protections of BAA and/or NDA and limit further use of such information to those purposes that make the return or destruction of such information infeasible.